Kohlberg & Mubadala Acquire Majority Stake in PCI Pharma Services

Bain Capital and Kohlberg Lead Strategic Investment in PCI Pharma Services

July 14, 2025

Healthcare Services

PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), received a strategic growth investment co-led by Bain Capital and existing lead investor Kohlberg, with significant reinvestment from Mubadala and a continuing minority stake from Partners Group. The capital will be used to accelerate PCI's organic and inorganic growth, expand sterile fill-finish and specialized manufacturing capacity, and broaden its geographic footprint to support biopharma customers and U.S. pharmaceutical supply-chain resilience.

PCI Pharma Services Acquires Bellwyck Pharma Services

February 11, 2020

Healthcare Services

PCI Pharma Services announced the acquisition of Bellwyck Pharma Services, a Toronto-headquartered clinical and commercial packaging, labeling and clinical trial services provider. The deal adds four GMP-compliant facilities in the U.S., Germany and Canada to PCI's global network and expands PCI's clinical trial service footprint into Canada and continental Europe.

PCI Pharma Services Acquires Ajinomoto Althea

May 1, 2025

Healthcare Services

PCI Pharma Services has completed the acquisition of Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO previously owned by Ajinomoto Co., Inc. The deal expands PCI’s US sterile manufacturing footprint in San Diego—adding prefilled syringe and cartridge aseptic capabilities, lyophilization and high-potent vial filling (including ADC support)—and is part of a multi-year, roughly $1 billion investment strategy to broaden advanced drug delivery and fill‑finish capacity.

Celestica Acquires PCI Limited from Platinum Equity

September 21, 2021

Manufacturing

Celestica Inc. agreed to acquire PCI Limited, a Singapore-based electronics manufacturing services (EMS) provider, from Platinum Equity for $306 million in cash. The deal, announced September 21, 2021, expands Celestica's manufacturing and design capabilities across Asia and is expected to close in mid-Q4 2021 subject to regulatory approvals.

Warburg Pincus and Mubadala Acquire Pharma Intelligence from Informa

June 1, 2022

Data & Analytics

Warburg Pincus, joined by Mubadala Investment Company, completed the acquisition of Pharma Intelligence (the Citeline suite and related specialist brands) from Informa PLC, with Informa retaining a 15% equity stake. The investors said they will invest in product development and innovation to expand Pharma Intelligence's position in the pharmaceutical data and analytics market; Jay Nadler was appointed Executive Chair following completion.

Kohlberg & Company Acquires Majority Stake in Engage PEO

August 9, 2023

Staffing & HR

Kohlberg & Company has acquired a majority stake in Engage PEO, a Fort Lauderdale-based professional employer organization, partnering with existing investor Lightyear Capital and Engage management, both of which will retain minority stakes. The investment positions Kohlberg to accelerate Engage's organic growth and M&A-driven consolidation across the PEO/human capital management market in the U.S.